Skip Navigation

Europace 2008 10(5):540-544; doi:10.1093/europace/eun082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gibson, D. P.
Right arrow Articles by Ellenbogen, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, D. P.
Right arrow Articles by Ellenbogen, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org


ICDs

Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator

Douglas P. Gibson1,*, Kristin K. Kuntz2, James L. Levenson1 and Kenneth A. Ellenbogen3

1 Virginia Commonwealth University School of Medicine, 1200 East Broad Street, PO Box 980268, Richmond, VA 23298-0268, USA; 2 Ohio State University Comprehensive Transplant Center, 700 Kinnear Road, Columbus, OH 43212, USA; 3 Virginia Commonwealth University School of Medicine, 1001 East Broad Street, PO Box 980053, Richmond, VA 23298-0268, USA

Aims: We sought to investigate whether patients with implantable cardioverter defibrillators (ICDs) were suffering from emotional distress related to the recent United States Food and Drug Administration (FDA) recalls, to better understand their decision process related to device replacement, and to assess any impact of recall on quality of life (QOL).

Methods and results: Thirty-one patients experiencing device recalls answered questions regarding their knowledge about the recall and their decision whether to replace the device. Fifty patients whose devices were not recalled reported demographic data. In both groups, psychological factors were assessed. No significant differences were found for psychological factors. Most patients reported being informed of their recall by their physician. Most estimated the risk of device failure to be low or very low, but they overestimated the fail rate. Thirty-six per cent of patients reported feeling anxious about the recall.

Conclusion: No significant differences existed in psychological factors and QOL between patients whose ICDs were recalled compared with those whose devices were not. The majority of patients whose ICDs are the subject of an FDA advisory/recall have a realistic understanding of the risks of device failure. Prompt information, support, and reassurance provided by healthcare professionals may allay patient distress.

Key Words: Implantable cardioverter defibrillator, Food and Drug Administration recall, Psychological factors, Quality of life


* Corresponding author. Tel: +1 804 828 4919; fax: +1 804 828 0220. E-mail address: dgibson{at}mcvh-vcu.edu

Manuscript submitted 20 December 2007. Accepted after revision 16 March 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.